An Exploratory, Multi-cohort Phase II Study of Combination Therapy With AK104 and AK112 for Recurrent Ovarian Cancer

QL1706 Combined With Chemotherapy and Anlotinib for the Treatment of Recurrent Ovarian Cancer

NCT07286240 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treatment of Advanced Ovarian Cancer

NCT06542549 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

NCT06600841 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

AK104 Combined With Chemotherapy as Neoadjuvant Treatment for Advanced Ovarian Cancer

NCT05430906 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy Study of Nuc-1031 and Carboplatin Combination to Treat Recurrent Ovarian Cancer

NCT02303912 ·Status: COMPLETED ·Phase: PHASE1

The Culture of Advanced or Recurrent Ovarian Cancer Organoids and Drug Screening

NCT05290961 ·Status: UNKNOWN

HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer

NCT06855069 ·Status: RECRUITING ·Phase: PHASE3

Niraparib Plus Anlotinib for Recurrent Ovarian Cancer

NCT05311579 ·Status: UNKNOWN ·Phase: PHASE2

Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT03776812 ·Status: COMPLETED ·Phase: PHASE2

Secondary Cytoreduction Followed by Chemotherapy Versus Chemotherapy Alone in Relapsed Ovarian Cancer After PARPi Maintenance Treatment: a Multicentre, Open-label, Randomised, Phase 3 Trial

NCT05607329 ·Status: RECRUITING ·Phase: NA

SHR - A1811 Injection in the Treatment of Platinum-sensitive Recurrent Ovarian Cancer

NCT06990516 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2

Study of Predictive Factors of Chemoresistance in Ovarian Cancer

NCT02878122 ·Status: COMPLETED

Testing the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial Cancers

NCT05691504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors

NCT06873555 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer

NCT00004060 ·Status: COMPLETED ·Phase: PHASE2

Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer

NCT04337632 ·Status: UNKNOWN ·Phase: PHASE3

Oxaliplatin and Fluorouracil in Treating Patients With Recurrent Ovarian Cancer

NCT00004206 ·Status: UNKNOWN ·Phase: PHASE2

Adaptive ChemoTherapy for Ovarian Cancer in Patients With Replased Platinum-sensitive High Grade Serous or High Grade Endometrioid Ovarian Cancer

NCT05080556 ·Status: RECRUITING ·Phase: PHASE2

SHR - A1811 Versus Chemotherapy for Platinum-resistant Recurrent Epithelial Ovarian Cancer

NCT06990503 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Carboxyamidotriazole in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

NCT00019461 ·Status: COMPLETED ·Phase: PHASE2

Phase III Trial of Stage I Ovarian Cancer After Surgery

NCT04063527 ·Status: RECRUITING ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of NKTR-102 in Patients With Metastatic or Locally Advanced Ovarian Cancer

NCT00806156 ·Status: COMPLETED ·Phase: PHASE2

Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC

NCT06341907 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer

NCT00466986 ·Status: COMPLETED ·Phase: PHASE2

A Comparative Study of the Treatment of Real-world Patients With Clear Cell Carcinoma of the Ovary

NCT06279104 ·Status: RECRUITING